Joint working agreements and transfers of value

We work with other organisations to make sure health and social care services have access to the latest innovations to improve patient care and enable efficiencies.

A joint working agreement (JWA) provides a common reference point which formalises this collaborative relationship, the responsibilities and boundaries for each partner.

Our current joint working agreements and transfers of value (ToVs)

The information below outlines joint working agreements and transfers of value between Health Innovation East and commercial organisations in support of programmes of work that aim to improve the health and care system in the East of England.

Organisations involved Programme or activity Start date End date Monetary or in-kind value Summary of benefit
Health Innovation East and Bayer PLC (UK) Staff secondment (Healthcare Partnership Manager – one day per week) April 2020 April 2023 In-kind value: one day per week – Healthcare Partnership Manager at Bayer PLC (UK) Supporting the work of teams across Health Innovation East.
Health Innovation East, Janssen-Cilag Limited, Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) and National Institute for Health and Care Research: Applied Research Collaboration – East of England (NIHR ARC) ‘i-VALiD: informing values-based practice in persistent depression’ July 2020 Dec 2022 £105,978

Grant – medical educational goods and services (MEGS)

Grant funding to support two postdoctoral posts to conduct clinical and health economic evaluation of patients with persistent depression across CPFT. To build an evidence base for service redesign in mental health.
Health Innovation East and AstraZeneca UK Ltd. ‘Multimorbid patient care optimisation across the East of England’ February 2021 End April 2023 £139,625 from AstraZeneca (matched by Health Innovation East) Development and provision of educational content including – the time and contribution of a medical writer, educator and a project manager. Analysis of real-world evidence. The oversight of a senior team on a joint steering committee.
Health Innovation East, Amicus Therapeutics UK Ltd., BioMarin (U.K.) Limited, Sanofi UK, Takeda UK Limited, Royal College of Nursing and Open Health Communications LLP ‘Online educational platform for nurses working in or interested in Lysosomal Storage Disorders (LSD)’ May 2021 May 2023 £149,370

Grant – medical educational goods and services (MEGS)

Grant funding to develop an accredited online educational platform for nurses working in the field of Lysosomal Storage Disorders. Supporting the development, project management and content management of a Learning Management System (LMS) by medical communications agency (Open Health). Supporting the accreditation process through the Royal College of Nursing for at least two years.
Health Innovation East and Bayer PLC The Scale-Up Academy  1 November 2022 10 March 2023 £24,000


Scale-Up Academy: Sponsorship of eight (8) places for companies to attend the Scale-Up Academy

Health Innovation East: Enabling innovators to help tackle the healthcare scale-up challenges by overcoming the barriers to commercial success

Bayer: Recognition of programme sponsorship. Professional development opportunity for Bayer staff in support of participating organisations

Health Innovation East and Abbott Staff secondment (Market Access Specialist – two days per month) Jan 2023 Dec 2023 In-kind value: Two days per month – Market Access Specialist Abbott Diabetes Care Supporting the work of teams across Health Innovation East.
Health Innovation East and Amgen Limited Advisor at a Market Access advisory board meeting 20 June 2023 20 June 2023 £896 (excluding VAT) Health Innovation East has been invited to join a virtual advisory board to explore the concept of a value-based approach to optimising the lipid pathway for patients deemed high-risk.
Health Innovation East and Daiichi Sankyo East of England Stroke Forum Annual Conference September 2023 September 2023 £12,578.00 + VAT Daiichi Sankyo are sponsoring a conference for healthcare professionals involved in stroke care.

This meeting has been organised by Health Innovation East and sponsored through funding by Daiichi Sankyo. Daiichi Sankyo has had no involvement in the organisation of the meeting which Health Innovation East is coordinating as hosts of the East of England Stroke Forum

Health Innovation East and Irwin Mitchell East of England Stroke Forum Annual Conference September 2023 September 2023 £2000+ VAT Irwin Mitchell are sponsoring videography at a conference for healthcare professionals involved in stroke care, enabling presentations from keynote speakers to be watched by more clinicians.

Little Journey

Reducing anxiety in children through virtual reality

Measuring fractional exhaled nitric oxide (FeNO) concentration in asthma

FeNO testing is a method of diagnosing asthma by measuring fractional exhaled nitric oxide (FeNO) in the breath of patients. It aims to improve patient care and outcomes by more effective diagnosis of patients suspected of having asthma. Rollout supported nationally by the AHSN Network as part of the Rapid Uptake Product (RUP) programme.

Medic Bleep

Medic Bleep enables hospital and community staff to communicate and collaborate within and across organisations, sharing vital information about patients accurately and safely whilst also save time.
Health Innovation East supported the evaluation of both a pilot and wider roll out across West Suffolk NHS Foundation Trust.


MediShout provides a digital platform to integrate all logistical departments, giving clinicians an app to instantly report any issue and track the progress to resolution, while using artificial intelligence (AI) to predict future problems.


MySpira is an app that uses augmented reality and gameplay to help children between the ages of 6–13 years learn about asthma and proper inhaler technique, to reduce the number of children admitted to hospitals for incorrect use of inhalers.

Opioid deprescribing toolkit

The Health Innovation East is working in partnership with the ARC and Norfolk and Waveney CCG to improve the quality of life of people living with chronic pain and reducing the harm caused by opioids and other dependence forming medication.
We are working with senior NHS staff and patients to pilot a toolkit for clinicians to aid the deprescribing of opioids in the region.

Placental growth factor (PlGF) based testing

PlGF-based testing can help with clinical risk stratification for women with suspected pre-eclampsia, meaning they can be treated appropriately according to their need, improving both patient experience and outcomes.

The National Patient Safety Improvement Programmes (NatPatSIPs)

The National Patient Safety Improvement Programmes (NatPatSIPs) support a culture of safety, continuous learning and sustainable improvement across the healthcare system.

The Mental Health Safety Improvement Programme (MH-SIP)

This programme aims to improve the safety by reducing harm caused to people using mental health, learning disabilities and autism inpatient services by 2023.

The MedTech Funding Mandate (MTFM)

The MedTech Funding Mandate (MTFM) is an NHS Long Term Plan commitment to give patients access to selected NICE approved, cost-efficient technologies more quickly. We are working with suppliers to support trusts to implement the selected innovations, understand local and regional issues and share learnings from NHS organisations who have already implemented them.

Share your idea

Do you have a great idea that could deliver meaningful change in the real world?

Get involved